Cadrenal Therapeutics, Inc. Common Stock (CVKD) Technical Analysis
$2.05
Insights
- Cadrenal Therapeutics Inc. is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
- Based on analysis of the Oscillators technical indicator, the current market trend for Cadrenal Therapeutics Inc. stock suggests that it is a good time to buy
- Based on analysis of the Moving Averages technical indicator, Cadrenal Therapeutics Inc. stock is in a downtrend↘️
- Based on analysis of the Pivot Points, the current market trend for Cadrenal Therapeutics Inc. stock suggests that it is a good time to sell or bad time to initiate a fresh position
Analysis Summary
Oscillators
Sell
Neutral
Buy
Moving Averages
Sell
Neutral
Buy
Pivots
Sell
Neutral
Buy
Oscillators
Name | Value | Action |
|---|---|---|
Relative Strength Index | 28.3 | Buy |
Stochastic | 2.72, 3.1 | Neutral |
Ultimate Oscillator | 23.24 | Buy |
Stochastic Relative Strength Index | 7.05, 3.78 | Buy |
Moving Average Convergence Divergence | -0.47, -0.44 | Neutral |
Moving Averages
Simple Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 2.39 | Sell |
20 | 2.78 | Sell |
50 | 3.77 | Sell |
Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 2.39 | Sell |
20 | 2.74 | Sell |
50 | 3.6 | Sell |
Volume Weighted Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 2.48 | Sell |
20 | 2.89 | Sell |
50 | 3.69 | Sell |
Double Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 2.05 | Sell |
20 | 2.11 | Sell |
50 | 2.42 | Sell |
Triple Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 2.02 | Sell |
20 | 2.06 | Sell |
50 | 2.07 | Sell |
Pivot
Pivot | Value |
|---|---|
Resistance L3 | 2.62 |
Resistance L2 | 2.5 |
Resistance L1 | 2.34 |
Pivot Point | 2.22 |
Support L1 | 2.05 |
Support L2 | 1.93 |
Support L3 | 1.77 |
*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.